The board of directors of Nasdaq-listed company Anixa Biosciences has approved the purchase of Bitcoin as a reserve asset
Bitget2024/11/22 13:58
According to PR Newswire, Anixa Biosciences, Inc. (NASDAQ: ANIX), a Nasdaq-listed company in the United States, announced that its board of directors has approved the purchase of Bitcoin as a treasury reserve asset with the aim of diversifying the company's assets and enabling Anixa to benefit from the potential long-term value of digital assets. It is reported that Anixa is a clinical-stage biotechnology company focused on cancer treatment and prevention.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Locked for new tokens.
APR up to 10%. Always on, always get airdrop.
Lock now!
You may also like
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$94,736.79
-3.60%
Ethereum
ETH
$3,431.37
+1.24%
Tether USDt
USDT
$1
-0.03%
Solana
SOL
$238.75
-5.97%
BNB
BNB
$644.24
-2.66%
XRP
XRP
$1.45
-0.99%
Dogecoin
DOGE
$0.4080
-4.08%
USDC
USDC
$1
+0.02%
Cardano
ADA
$0.9829
-6.19%
Avalanche
AVAX
$42.08
-0.30%
Bitget pre-market
Buy or sell coins before they are listed, including ZRC, XION, OGC, MEMEFI, and more.
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new Bitgetters!
Sign up now